Tansna Therapeutics Overview
- Year Founded
-
2010
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Tansna Therapeutics General Information
Description
Developer of novel drugs intended to improve the lives of patients suffering from debilitating disorders. The company's novel drugs are safe, oral and anticonvulsant agents that effectively reduce seizure frequency in patients with epilepsy, enabling physicians to treat their patients in an enhanced way.
Contact Information
Website
www.tansna.comCorporate Office
- 4320 Forest Park Avenue
- Suite 303
- Saint Louis, MO 63108
- United States
Corporate Office
- 4320 Forest Park Avenue
- Suite 303
- Saint Louis, MO 63108
- United States
Tansna Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 01-Sep-2018 | Completed | Out of Business | |||
| 4. Early Stage VC (Series A) | 26-Feb-2014 | Completed | Generating Revenue | |||
| 3. Seed Round | 19-Feb-2013 | Completed | Generating Revenue | |||
| 2. Grant | 25-Oct-2012 | $15K | Completed | Startup | ||
| 1. Grant | 01-Jan-2011 | $181K | Completed | Startup |
Tansna Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Tansna Therapeutics Comparisons
Industry
Financing
Details
Tansna Therapeutics Competitors (38)
One of Tansna Therapeutics’s 38 competitors is AnTolRx, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
| Regenacy Pharmaceuticals | Venture Capital-Backed | Waltham, MA | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| EyeD Pharma | Venture Capital-Backed | Seraing, Belgium | ||||
| Orbsen Therapeutics | Private Equity-Backed | Galway, Ireland |
Tansna Therapeutics Patents
Tansna Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2016190871-A1 | 2,5-dialkyl-4-h/halo/ether-phenol compounds | Inactive | 28-May-2015 | ||
| US-20150148430-A1 | 2,5-dialkyl-4-h/halo/ether-phenol compounds | Active | 22-Nov-2013 | ||
| US-20170174600-A1 | 2,5-dialkyl-4-h/halo/ether-phenol compounds | Inactive | 22-Nov-2013 | ||
| US-9630896-B2 | 2,5-dialkyl-4-h/halo/ether-phenol compounds | Inactive | 22-Nov-2013 | C07C39/06 |
Tansna Therapeutics FAQs
-
When was Tansna Therapeutics founded?
Tansna Therapeutics was founded in 2010.
-
Where is Tansna Therapeutics headquartered?
Tansna Therapeutics is headquartered in Saint Louis, MO.
-
What industry is Tansna Therapeutics in?
Tansna Therapeutics’s primary industry is Drug Discovery.
-
Is Tansna Therapeutics a private or public company?
Tansna Therapeutics is a Private company.
-
What is Tansna Therapeutics’s current revenue?
The current revenue for Tansna Therapeutics is .
-
How much funding has Tansna Therapeutics raised over time?
Tansna Therapeutics has raised $949K.
-
Who are Tansna Therapeutics’s competitors?
AnTolRx, Regenacy Pharmaceuticals, Genentech, EyeD Pharma, and Orbsen Therapeutics are some of the 38 competitors of Tansna Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process